Understanding PACS2 syndrome's pathomechanism by studying E209K and E211K mutations

Area of Science:

• Cellular Biology
• Genetics
• Neuroscience

Background:

• Phosphofurin acidic cluster sorting protein 2 (PACS2) is crucial for cellular homeostasis, regulating protein trafficking and impacting apoptosis, calcium flux, and autophagy.
• Missense mutations in PACS2, specifically E209K and E211K, are associated with developmental and epileptic encephalopathy-66 (DEE66), or PACS2 syndrome, characterized by neurodevelopmental delays and seizures.

Purpose of the Study:

• To review the current understanding of PACS2 structure and function.
• To explore the cellular consequences of E209K and E211K mutations in PACS2.
• To highlight the potential of induced pluripotent stem cells (iPSCs) and animal models for studying PACS2 syndrome.

Main Methods:

• Literature review of PACS2 function and associated mutations.
• Analysis of cellular effects of PACS2 mutations, including phosphorylation and protein-protein interactions.
• Discussion of iPSC and mouse models for in vitro and in vivo studies of PACS2 syndrome.

Main Results:

• The E209K mutation in PACS2 is linked to decreased phosphorylation, altered protein stability, and disrupted protein interactions, impacting calcium flux and apoptosis resistance.
• Current research on PACS2 syndrome is limited by a lack of suitable disease models.
• iPSC and mouse models show promise for investigating disease mechanisms and phenotypic diversity.

Conclusions:

• Understanding the molecular impact of PACS2 mutations is vital for deciphering PACS2 syndrome.
• iPSC and animal models are essential for overcoming limitations of current in vitro studies and advancing research.
• Further development and utilization of these models are crucial for understanding PACS2 syndrome and developing personalized therapies.